Clinical manifestations and outcomes of COVID-19 in maintenance hemodialysis patients of a high infectious epidemic country: a prospective cross-sectional study
- PMID: 37663710
- PMCID: PMC10473334
- DOI: 10.1097/MS9.0000000000001046
Clinical manifestations and outcomes of COVID-19 in maintenance hemodialysis patients of a high infectious epidemic country: a prospective cross-sectional study
Abstract
Introduction: The outbreak of COVID-19 poses great challenges for patients on maintenance haemodialysis. Here, we reported the clinical characteristics and laboratory features of maintenance haemodialysis (MHD) patients with COVID-19 in Bangladesh.
Methods: Altogether, 67 MHD patients were enroled in the study from two dedicated tertiary-level hospitals for COVID-19 after the prospective cross-sectional execution of selection criteria. Data were collected from medical records and interviews. Different statistical analysis was carried out in the data analysis.
Results: The mean age was 55.0±9.9 years, with 40 males (59.7%). The mean dialysis duration was 23.4±11.5 months. The most common symptoms were fever (82.1%), cough (53.7%), and shortness of breath (55.2%), while the common comorbid condition was hypertension (98.5%), followed by diabetes (56.7%). Among MHD patients, 52.2% to 79.1% suffered from severe to critical COVID-19, 48 patients (71.6%) had 26-75% lung involvement on high resolution computed tomography of the chest, 23 patients (34.3%) did not survive, 20 patients (29.9%) were admitted to ICU, and nine patients (13.4%) needed mechanical ventilation. Patients who did not survive were significantly older (mean age: 63.0 vs. 50.86 years, P=0.0001), had significantly higher cardiovascular risk factors (69.6% vs. 43.2%, P=0.04), severe shortness of breath (82.6% vs. 40.9%, P=0.0001), and longer hospital stays (mean days: 17.9 vs. 13.0, P=0,0001) compared to the survivor group. The white blood cell count, C-reactive protein, lactate dehydrogenase, pro-calcitonin, and thrombocytopenia were significantly (P<0.0001) higher, while the albumin level was significantly lower (P=0.0001) in non-survivor compared to patients who survived.
Conclusion: Maintenance haemodialysis patients had severe to critical COVID-19 and had a higher risk of non-survival if they were older and had comorbidities such as hypertension and diabetes. Therefore, MHD patients with COVID-19 need close monitoring to improve their outcomes.
Keywords: Bangladesh; clinical manifestations; COVID-19; maintenance haemodialysis; mortality.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare that they have no competing interests.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Similar articles
-
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.BMC Nephrol. 2021 Jan 14;22(1):29. doi: 10.1186/s12882-021-02233-0. BMC Nephrol. 2021. PMID: 33446135 Free PMC article.
-
Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 - A Single Centre Experience.Cureus. 2021 Aug 14;13(8):e17170. doi: 10.7759/cureus.17170. eCollection 2021 Aug. Cureus. 2021. PMID: 34548976 Free PMC article.
-
A retrospective cross-sectional study on the risk factors and survival outcome of End Stage Kidney Disease patients receiving regular maintenance haemodialysis with COVID-19 infection in Hospital Enche' Besar Hajjah Khalsom, Kluang.Med J Malaysia. 2021 Nov;76(6):845-852. Med J Malaysia. 2021. PMID: 34806671
-
Mortality and risk factors for COVID-19 in hemodialysis patients: A systematic review and meta-analysis.Sci Prog. 2022 Jul-Sep;105(3):368504221110858. doi: 10.1177/00368504221110858. Sci Prog. 2022. PMID: 35775141 Free PMC article.
-
Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863. Epub 2021 Jan 27. Ann Palliat Med. 2021. PMID: 33548996
Cited by
-
The global burden of overweight-obesity and its association with economic status, benefiting from STEPs survey of WHO member states: A meta-analysis.Prev Med Rep. 2024 Sep 5;46:102882. doi: 10.1016/j.pmedr.2024.102882. eCollection 2024 Oct. Prev Med Rep. 2024. PMID: 39290257 Free PMC article. Review.
References
-
- Haque MF, Rahman MM, Alif SM, et al. . Estimation and prediction of doubling time for COVID-19 epidemic in Bangladesh: a modelling study of first 14 month’s daily confirmed new cases and deaths. Glob Biosec 2021;3. 10.31646/gbio.91 - DOI
-
- World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum. Published February 2020. Accessed August 1, 2022. https://www.who.int/publications/m/item/covid-19-public-health-emergency...
LinkOut - more resources
Full Text Sources
Research Materials